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Genotype-phenotype relationship study in a large cohort of 
1717-1G-->A/DeltaFS08 CF patients. 
I. Dugu~l~r oux, M. De  Braekeleer 
FacuItd de Mddecine & CHU Morva~ Brest, France 
We report here data from the French CF registry on 67 CF patients bearing the 
1717 1G >A/DeltaF508 genotype. Each compound heter ozygote was matched to a 
AF508 homozygote of same sex, age (+ 1 year) and attending the same CF care 
network. 
Both populations were 13 years old at the t ime of the study, 76% of the patients 
being younger than 20 years. The mean age at diagnosis was similar in both groups: 
18.5 months + 31.7 versus 20.1 + 33.2 respectively. No difference was found in the 
clinical clues at the t ime of diagnosis, except for a higher frequency of meconium 
ileus among the 1717 1G >A/AF508 patients (24.2% versus 10.9% P 0.04). Both 
groups had poor nutritional status and a mean BMI  under normal values (16.7 
versus 16.8 kg/m~). The mean FEV 1 scores were below 75%. The mean FVC score 
was lower, but not significantly, in the 1717 1G >A/AF508 group than among the 
AF508 homozygotes (77.7 + 23.4 versus 86.8 + 22.9 % of predicted value; p 
0.07). However, the median values were closer: 83.3 % versus 85.8%. The mean 
sweat chloride concentration and the prevalence of cl inical events, s~ach as l iver 
cirrhosis and mellitus diabetes, were similar in both groups. Almost all patients 
were pancreatic insnfficient. 
In conclusion, the 1717 1G>A al lele leads to a severe phenotype indistinguishable 
from the AF508 mutation, but for an increased risk of meconium ileus. 
The authors thank the participating centres and the INED team ha charge of the 
management of the French CF Registry. Ingrid Dugugl~roux is the recipient of a 
post <lc~tor al fel lowship from "Vaincre la Mucoviscidose". 
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CFTR mutations and polymorphisms in patients with disseminated 
bronchiectasis 
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We tested the possible involvement of CF IR  mutations and polymotphisms in 
etiology of disseminated bronchiectasis (DE) of unknown cause, in 19 Serbian 
patients 
The whole coding region and intr onic boundaries of the CFFR gene were analyzed 
by denatur ing gradient gel  electropboresis (DGGE) mad subsequent DNA 
sequencing. 
In 2/19 patients, two different CFTR mutations were detected. One patient was a 
compound heterozygote (V920L/R75Q) and one was heterozygous for R75Q. The 
cumulative allelic frequency of mutations was 7.9% (3/38 alleles). IVS8 5T al lele 
was not found ha any of the patients. The incidence of the M470 al lele was 28.9% 
(11/38 alleles). Several common silent mutations (1716G/A, 2694T/G, 4002A/C~ 
4404C/T) and nucleotide changes ha non coding regions (875+40A/G, GATT6/7, 
1011+11C/T) were identified. 
Frequency of CFTR mutations obtained ha this study was not significantly higher 
than in general population and our results do not indicate a maj or role of CFFR gene 
mutations ha the etiology of DB. In spite of the facts that the clinical selection of 
patients was strict mad that the complete coding region of the CFTR gene was 
screened, due to the small sample size, these results should be considered 
preliminary and need to be confirmed in a larger study. Recent publications by K ing 
et al and Casals et al reported controversial results regarding the involvement of 
CFFR ha development of DB, so further multicentre studies on a larger cobott of 
clinically wel l  defined patients are needed to resolve these conflicting results. 
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Detection of Cystic Fibrosis mutations in echogenic bowel 
M Tzetis, A Tsiamouri, A Papatheodor u, K Pouliou, E Keaaavakis 
Dept of Medical Genetics, University of Athens, St. Sophia's ChiMren's Hospital, 
Athens, Greece 
The presence of echogenic bowel detected on ultrasound investigation during the 
second trimester of preDaancy can be a normal variant and also associated with 
cystic fibrosis, as wel l  as a number of other disorders such as cbromosome 
aneuploidy. We have investigated 91 cases of echogenic bowel and have detected 
cystic fibrosis homozygosity in four of these (4.3%) with the fol lowing genotypes: 
F508del/L732X, F508del/574delA, F508del/F508del, F508del/G542X. In addition 
heterozygosity was observed in 15 cases (13.4%): 9 with F508del 2 with 621 +IG>T 
and 1 case each for I148T, 2789+5G>A, R297Q and E822X. An  additional f inding 
was the presence of particular polymotpbisms: 3 instances of 1716G/A (E528E), 2 
of 2752 15G/C, 2 of R l162L  and 1 of 4029A/G. Our data indicated that the prior 
r isk of CF in a fetus with echogenic bowel for our population is 4.3% and the 
remaining risk of an heterozygous fetus having CF is between 10.3 and 20%. 
Table 1: Summary of familiez tezted and CF rezultz 
Both parents and/or fetus negative 
One parent cartier fetus negative 
One parent cartier fetus not tested 
One parent cartier fetus cartier 
Both parents carriers fetus affected 
Fetuz only tezted negative 
Fetuz only tezted cartier 
Coup~ on~zted  both negative 
TOTAL 
21 
2 I148T, F308del 
5 69 I+3A>G, R75Q and 3 with 
F308del, 







8 E822X; ?789+3G>A; 
67 I+IG>T; R297Q; 
and 4 F308del 
26 
91 4 homozygotez and 15 
heterozygotez 
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Influence of Interleukin-1O on airways colonizafion by Aspergillus 
fumigatus in cystic fibrosis patients 
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Recent evidence suggests that genetic variants affecting the production of 
interleukin (IL) 10 may play a role in the response to pathogens ha cystic fibrosis 
(CF). The study was designed to seek for an association between alleles carried at
position 1082of the lL  10promoter and phenotypical data from 378 patients with 
CF. After adjusting for potential confounding variables a significant relationship 
was found between the 1082GGgenotypeandbothAfumigatuscolonizationand 
allergic bronchopulmonary aspergillosis (ABPA). In addition, higher serum levels 
of IL  10 were observed ha patients chronically infected with Afurnigatus, and this 
was associated with a significant increased frequency of 1082G allele. These 
genetic and functional studies suggest that promoter variants of IL  10 may 
predispose to develop A fumigatus colonization and ABPA ha CF. 
